Literature DB >> 21340043

Design and Testing of a Pulsatile Conditioning System for Dynamic Endothelialization of Polyphenol-Stabilized Tissue Engineered Heart Valves.

Leslie Neil Sierad1, Agneta Simionescu, Christopher Albers, Joseph Chen, Jordan Maivelett, Mary Elizabeth Tedder, Jun Liao, Dan T Simionescu.   

Abstract

Heart valve tissue engineering requires biocompatible and hemocompatible scaffolds that undergo remodeling and repopulation, but that also withstand harsh mechanical forces immediately following implantation. We hypothesized that reversibly stabilized acellular porcine valves, seeded with endothelial cells and conditioned in pulsatile bioreactors would pave the way for next generations of tissue engineered heart valves (TEHVs). A novel valve conditioning system was first designed, manufactured and tested to adequately assess TEHVs. The bioreactor created proper closing and opening of valves and allowed for multiple mounting methods in sterile conditions. Porcine aortic heart valve roots were decellularized by chemical extractions and treated with penta-galloyl glucose (PGG) for stabilization. Properties of the novel scaffolds were evaluated by testing resistance to collagenase and elastase, biaxial mechanical analysis, and thermal denaturation profiles. Porcine aortic endothelial cells were seeded onto the leaflets and whole aortic roots were mounted within the dynamic pulsatile heart valve bioreactor system under physiologic pulmonary valve pressures and analyzed after 17 days for cell viability, morphology, and metabolic activity. Our tissue preparation methods effectively removed cells, including the potent α-Gal antigen, while leaving a well preserved extra-cellular matrix scaffold with adequate mechanical properties. PGG enhanced stabilization of extracellular matrix components but also showed the ability to be reversible. Engineered valve scaffolds encouraged attachment and survival of endothelial cells for extended periods and showed signs of widespread cell coverage after conditioning. Our novel approach shows promise toward development of sturdy and durable TEHVs capable of remodeling and cellular repopulation.

Entities:  

Year:  2010        PMID: 21340043      PMCID: PMC3039844          DOI: 10.1007/s13239-010-0014-6

Source DB:  PubMed          Journal:  Cardiovasc Eng Technol        ISSN: 1869-408X            Impact factor:   2.495


  36 in total

1.  Optimized growth conditions for tissue engineering of human cardiovascular structures.

Authors:  S P Hoerstrup; G Zund; A M Schnell; S A Kolb; J F Visjager; A Schoeberlein; M Turina
Journal:  Int J Artif Organs       Date:  2000-12       Impact factor: 1.595

2.  Functional living trileaflet heart valves grown in vitro.

Authors:  S P Hoerstrup; R Sodian; S Daebritz; J Wang; E A Bacha; D P Martin; A M Moran; K J Guleserian; J S Sperling; S Kaushal; J P Vacanti; F J Schoen; J E Mayer
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

3.  Complete dynamic repopulation of decellularized heart valves by application of defined physical signals-an in vitro study.

Authors:  K Schenke-Layland; F Opitz; M Gross; C Döring; K J Halbhuber; F Schirrmeister; Th Wahlers; U A Stock
Journal:  Cardiovasc Res       Date:  2003-12-01       Impact factor: 10.787

Review 4.  Heart valve bioprosthesis durability: a challenge to the new generation of porcine valves.

Authors:  M Valente; M Minarini; A F Maizza; U Bortolotti; G Thiene
Journal:  Eur J Cardiothorac Surg       Date:  1992       Impact factor: 4.191

5.  Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch.

Authors:  Ching-Hsin Ku; Philip H Johnson; Puspa Batten; Padmini Sarathchandra; Rachel C Chambers; Patricia M Taylor; Magdi H Yacoub; Adrian H Chester
Journal:  Cardiovasc Res       Date:  2006-04-07       Impact factor: 10.787

Review 6.  Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering.

Authors:  Frederick J Schoen
Journal:  Circulation       Date:  2008-10-28       Impact factor: 29.690

7.  Elastin stabilization for treatment of abdominal aortic aneurysms.

Authors:  Jason C Isenburg; Dan T Simionescu; Barry C Starcher; Narendra R Vyavahare
Journal:  Circulation       Date:  2007-03-19       Impact factor: 29.690

8.  Comparative study of target antigens for primate xenoreactive natural antibodies in pig and rat endothelial cells.

Authors:  A Azimzadeh; P Wolf; K Thibaudeau; J Cinqualbre; J P Soulillou; I Anegon
Journal:  Transplantation       Date:  1997-10-27       Impact factor: 4.939

9.  Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet.

Authors:  Jun Liao; Erinn M Joyce; Michael S Sacks
Journal:  Biomaterials       Date:  2008-03       Impact factor: 12.479

10.  Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients.

Authors:  P Simon; M T Kasimir; G Seebacher; G Weigel; R Ullrich; U Salzer-Muhar; E Rieder; E Wolner
Journal:  Eur J Cardiothorac Surg       Date:  2003-06       Impact factor: 4.191

View more
  18 in total

1.  Functional Heart Valve Scaffolds Obtained by Complete Decellularization of Porcine Aortic Roots in a Novel Differential Pressure Gradient Perfusion System.

Authors:  Leslie Neil Sierad; Eliza Laine Shaw; Alexander Bina; Bryn Brazile; Nicholas Rierson; Sourav S Patnaik; Allison Kennamer; Rebekah Odum; Ovidiu Cotoi; Preda Terezia; Klara Branzaniuc; Harrison Smallwood; Radu Deac; Imre Egyed; Zoltan Pavai; Annamaria Szanto; Lucian Harceaga; Horatiu Suciu; Victor Raicea; Peter Olah; Agneta Simionescu; Jun Liao; Ionela Movileanu; Marius Harpa; Dan Teodor Simionescu
Journal:  Tissue Eng Part C Methods       Date:  2015-12       Impact factor: 3.056

Review 2.  EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology.

Authors:  M K Sewell-Loftin; Young Wook Chun; Ali Khademhosseini; W David Merryman
Journal:  J Cardiovasc Transl Res       Date:  2011-07-13       Impact factor: 4.132

3.  Platform technologies for decellularization, tunic-specific cell seeding, and in vitro conditioning of extended length, small diameter vascular grafts.

Authors:  George Fercana; Devon Bowser; Margarita Portilla; Eugene M Langan; Christopher G Carsten; David L Cull; Leslie N Sierad; Dan T Simionescu
Journal:  Tissue Eng Part C Methods       Date:  2014-09-29       Impact factor: 3.056

4.  Stabilized Collagen and Elastin-Based Scaffolds for Mitral Valve Tissue Engineering.

Authors:  Christopher Deborde; Dan Teodor Simionescu; Cristopher Wright; Jun Liao; Leslie Neil Sierad; Agneta Simionescu
Journal:  Tissue Eng Part A       Date:  2016-10-03       Impact factor: 3.845

Review 5.  Polyphenol uses in biomaterials engineering.

Authors:  Amin Shavandi; Alaa El-Din Ahmed Bekhit; Pouya Saeedi; Zohreh Izadifar; Adnan A Bekhit; Ali Khademhosseini
Journal:  Biomaterials       Date:  2018-03-13       Impact factor: 12.479

6.  Comparison of Mesenchymal Stem Cell Source Differentiation Toward Human Pediatric Aortic Valve Interstitial Cells within 3D Engineered Matrices.

Authors:  Bin Duan; Laura A Hockaday; Shoshana Das; Charlie Xu; Jonathan T Butcher
Journal:  Tissue Eng Part C Methods       Date:  2015-04-13       Impact factor: 3.056

Review 7.  Challenges in vascular tissue engineering for diabetic patients.

Authors:  Jhilmil Dhulekar; Agneta Simionescu
Journal:  Acta Biomater       Date:  2018-02-01       Impact factor: 8.947

8.  The performance of cross-linked acellular arterial scaffolds as vascular grafts; pre-clinical testing in direct and isolation loop circulatory models.

Authors:  Timothy Pennel; George Fercana; Deon Bezuidenhout; Agneta Simionescu; Ting-Hsien Chuang; Peter Zilla; Dan Simionescu
Journal:  Biomaterials       Date:  2014-05-09       Impact factor: 12.479

9.  Form Follows Function: Advances in Trilayered Structure Replication for Aortic Heart Valve Tissue Engineering.

Authors:  Dan T Simionescu; Joseph Chen; Michael Jaeggli; Bo Wang; Jun Liao
Journal:  J Healthc Eng       Date:  2012-06       Impact factor: 2.682

10.  Mitigation of diabetes-related complications in implanted collagen and elastin scaffolds using matrix-binding polyphenol.

Authors:  James P Chow; Dan T Simionescu; Harleigh Warner; Bo Wang; Sourav S Patnaik; Jun Liao; Agneta Simionescu
Journal:  Biomaterials       Date:  2012-10-24       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.